Characteristics | (N, %) |
Tumor origin | |
Ovary | 34 (36.2) |
Fallopian tube | 27 (28.7) |
Peritoneum | 6 (6.4) |
Adnex or peritoneum | 27* (28.7) |
Debulking surgery | |
Primary debulking surgery | 64 (68.1) |
Interval debulking surgery | 20 (21.3) |
No surgery | 10 (10.6) |
FIGO stage | |
I | 2 (2.1) |
II | 11 (11.7) |
III | 51 (54.3) |
IV | 30 (31.9) |
Histology | |
Serous adenocarcinoma | 94 (100) |
Differentiation grade | |
High grade (grade 2–3) | 94 (100) |
gBRCA status | |
Non-mutated | 89 (94.7) |
Unknown | 5 (5.3) |
*Nine had no surgery (including those regarded inoperable at surgery), 14 had neoadjuvant chemotherapy before surgery, and five were evaluated after upfront surgery.
FIGO, International Federation of Gynecology and Obstetrics; gBRCA, germline BRCA.